100 Participants Needed

Affective Control Training for Emotional Instability

(N-ACT Trial)

JA
NA
JA
Overseen ByJD Allen, PhD
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: University of California, Berkeley
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial tests a new program called Neurobehavioral Affective Control Training (N-ACT), designed to help individuals manage emotions better by reducing impulsivity and constant negative thinking. It targets those who often struggle to control their emotions, act without thinking, or dwell on negative thoughts. Participants will engage in training sessions with a coach over two months. Individuals living in California who face these emotional challenges might be suitable candidates. The trial compares this training program to a group that waits two months before starting the program. As an unphased trial, this study provides a unique opportunity to explore innovative emotional management techniques.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It is best to discuss this with the trial coordinators or your doctor.

What prior data suggests that this cognitive training program is safe for improving emotion regulation?

Research has shown that Neurobehavioral Affective Control Training (N-ACT) uses safe, non-invasive methods like real-time brain scans (fMRI) and brain wave monitoring (EEG) to help manage emotions. In earlier studies, healthy participants reported no major safety issues with this training, indicating that N-ACT is generally well-tolerated. Participants experienced no harmful effects, making it a promising option for those seeking to improve emotional control without the risks of more invasive treatments.12345

Why are researchers excited about this trial?

Researchers are excited about the Neurobehavioral Affective Control Training (N-ACT) technique because it offers a novel approach to managing emotional instability by directly targeting affective control through neurobehavioral training. Unlike traditional methods that may rely on medication or talk therapy alone, N-ACT focuses on enhancing emotional regulation skills through structured, real-time interventions. This technique could potentially lead to more rapid and sustainable improvements in emotional stability, offering a promising alternative to conventional treatments.

What evidence suggests that this cognitive training program is effective for improving emotion regulation?

Research shows that Neurobehavioral Affective Control Training (N-ACT), which participants in this trial may receive, might help people manage their emotions better. This program uses computer exercises to teach emotion management skills. In past studies, similar training reduced depression symptoms in people with major depressive disorder compared to those who did not receive the training. Additionally, practicing these emotional tasks made the brain's emotion-processing more efficient. These results suggest that N-ACT could help with impulsive behavior and overthinking related to emotions, common issues in emotion regulation problems.13567

Who Is on the Research Team?

JA

J.D. Allen, Ph.D.

Principal Investigator

University of California, Berkeley

ÅH

Åsa Hammar, Ph.D.

Principal Investigator

University of Bergen

SL

Sheri L. Johnson, Ph.D.

Principal Investigator

University of California, Berkeley

Are You a Good Fit for This Trial?

This trial is for adults with mood symptoms, emotional distress, impulsivity, and related mental health issues. Participants should be able to complete eight weekly sessions of cognitive training and various assessments. Those with severe psychiatric disorders or conditions that might interfere with the study are likely excluded.

Inclusion Criteria

Current residency in the state of California
Elevated levels of rumination and/or emotion-related impulsivity

Exclusion Criteria

I have had a brain tumor, neurological issues, or significant head injuries.
Insufficient English language literacy to understand study procedures (as assessed by self-report)
Careless or inattentive responding as indicated by failing 50% or more of 'attention check' items embedded in the online screening questionnaires, overly rapid responding, or qualitative review of long strings of identical entries on screening/baseline questionnaire items that suggest data invalidity
See 2 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Baseline Assessment

Participants complete a baseline assessment including self-report questionnaires, psychophysiology, and a neuropsychological battery

1 week
1 visit (in-person and remote)

Pre-intervention Ecological Momentary Assessment (EMA)

Participants complete one week of ecological momentary assessment before the intervention

1 week

Treatment

Participants undergo eight weekly sessions of cognitive training exercises with a coach

8 weeks
8 visits (in-person and remote)

Post-treatment Assessment

Participants complete a post-treatment assessment with comparable measures to baseline

1 week
1 visit (in-person)

Post-intervention Ecological Momentary Assessment (EMA)

Participants complete a second week of ecological momentary assessment after the intervention

1 week

Follow-up

Participants complete follow-up questionnaires administered remotely six weeks following their final training session

6 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • Neurobehavioral Affective Control Training
Trial Overview The trial tests a new program called Neurobehavioral Affective Control Training aimed at improving emotion regulation. It involves weekly sessions over two months, comparing immediate intervention participants to a waitlisted control group.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Group I: Waitlist controlExperimental Treatment1 Intervention
Group II: N-ACT without delayExperimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of California, Berkeley

Lead Sponsor

Trials
193
Recruited
716,000+

University of Bergen

Collaborator

Trials
306
Recruited
695,000+

University College, London

Collaborator

Trials
884
Recruited
38,770,000+

Published Research Related to This Trial

Affect Regulation Training (ART) significantly reduced depressive symptoms in 218 individuals with major depressive disorder compared to a waitlist control group, with a moderate effect size (d = 0.56).
Improvements in emotion regulation skills were identified as a key mechanism behind the effectiveness of ART, suggesting that enhancing these skills can be beneficial in treating depression.
Affect regulation training reduces symptom severity in depression - A randomized controlled trial.Berking, M., Eichler, E., Luhmann, M., et al.[2020]
An online training program significantly improved socioemotional skills in 448 adults, enhancing their emotional awareness, mindfulness, and emotion regulation strategies compared to a placebo control.
Sustained improvements in emotional skills were observed at a 6-month follow-up for participants who completed the training, suggesting the program may offer protective benefits against emotional challenges, particularly during stressful times like the COVID-19 pandemic.
Improvements in mindfulness, interoceptive and emotional awareness, emotion regulation, and interpersonal emotion management following completion of an online emotional skills training program.Smith, R., Persich, MR., Chuning, AE., et al.[2023]
A study using ultra-high field (7T) fMRI evaluated the reliability of brain activity related to emotion regulation across three sessions, highlighting the importance of consistent measurements for clinical biomarkers.
Key brain regions involved in emotion regulation, such as the ventrolateral and dorsolateral prefrontal cortex, demonstrated high test-retest reliability, suggesting they are strong candidates for future research on individual differences in emotion regulation and potential neurobiological markers for affective disorders.
Test-retest reliability of emotion regulation networks using fMRI at ultra-high magnetic field.Berboth, S., Windischberger, C., Kohn, N., et al.[2021]

Citations

NCT06226467 | Neurobehavioral Affective Control TrainingThe primary aim of this study is to examine the acceptability, efficacy, and feasibility of Neurobehavioral Affective Control Training (N-ACT) as a novel ...
2.pubmed.ncbi.nlm.nih.govpubmed.ncbi.nlm.nih.gov/39970439/
Protocol for a Pilot Randomized Waitlist-Controlled TrialThe N-ACT program uses computerized adaptive behavioral tasks to strengthen the affective control processes theoretically and empirically linked ...
Affective Control Training for Emotional InstabilityAffect Regulation Training (ART) significantly reduced depressive symptoms in 218 individuals with major depressive disorder compared to a waitlist control ...
Neurobehavioral Affective Control TrainingThe primary aim of this study is to examine the acceptability, efficacy, and feasibility of Neurobehavioral Affective Control Training (N-ACT) ...
Training the Emotional Brain: Improving Affective Control ...Here we show, using behavioral and fMRI measures, that 20 d of training on a novel emotional WM protocol successfully enhanced the efficiency of this ...
Neurobehavioral Affective Control TrainingOverview. The goal of this clinical trial is to test a new cognitive training program to improve emotion regulation in adults.
Cognitive Training for Emotion-Related Impulsivity and ...This research will evaluate a novel intervention, neurobehavioral affective control training (N-ACT), which is designed to target two trait-like facets of ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security